PCR-based detection of gene transfer vectors: application to gene doping surveillance

Athletes who illicitly use drugs to enhance their athletic performance are at risk of being banned from sports competitions. Consequently, some athletes may seek new doping methods that they expect to be capable of circumventing detection. With advances in gene transfer vector design and therapeutic gene transfer, and demonstrations of safety and therapeutic benefit in humans, there is an increased probability of the pursuit of gene doping by athletes. In anticipation of the potential for gene doping, assays have been established to directly detect complementary DNA of genes that are top candidates for use in doping, as well as vector control elements. The development of molecular assays that are capable of exposing gene doping in sports can serve as a deterrent and may also identify athletes who have illicitly used gene transfer for performance enhancement. PCR-based methods to detect foreign DNA with high reliability, sensitivity, and specificity include TaqMan real-time PCR, nested PCR, and internal threshold control PCR.

[1]  H. Haisma,et al.  Gene doping: an overview and current implications for athletes , 2013, British Journal of Sports Medicine.

[2]  W. Al-Soud,et al.  Identification and Characterization of Immunoglobulin G in Blood as a Major Inhibitor of Diagnostic PCR , 2000, Journal of Clinical Microbiology.

[3]  P. Simon,et al.  A quick one-tube nested PCR-protocol for EPO transgene detection. , 2012, Drug testing and analysis.

[4]  Jim F Huggett,et al.  Evaluation of digital PCR for absolute DNA quantification. , 2011, Analytical chemistry.

[5]  H. Stedman,et al.  Safety and Efficacy of Regional Intravenous (RI) Versus Intramuscular (IM) Delivery of rAAV1 and rAAV8 to Nonhuman Primate Skeletal Muscle. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[6]  Shahram Mohaghegh,et al.  Doping and the Latest Prohibited List of the World Anti-Doping Agency (WADA) , 2013 .

[7]  D. Ginzinger.  Gene quantification using real-time quantitative PCR: an emerging technology hits the mainstream. , 2002, Experimental hematology.

[8]  James M. Wilson,et al.  Molecular analysis of vector genome structures after liver transduction by conventional and self-complementary adeno-associated viral serotype vectors in murine and nonhuman primate models. , 2010, Human gene therapy.

[9]  D. Lewis,et al.  A facile nonviral method for delivering genes and siRNAs to skeletal muscle of mammalian limbs. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[10]  A. Nieß,et al.  Direct and long-term detection of gene doping in conventional blood samples , 2011, Gene Therapy.

[11]  D. Kuhns,et al.  Retrovirus gene therapy for X-linked chronic granulomatous disease can achieve stable long-term correction of oxidase activity in peripheral blood neutrophils. , 2010, Blood.

[12]  G. Acsadi,et al.  Conditions affecting direct gene transfer into rodent muscle in vivo. , 1991, BioTechniques.

[13]  Reconsideration of a Tour de France cyclist. , 2013, Journal of applied physiology.

[14]  Fumio Inagaki,et al.  Molecular quantification of environmental DNA using microfluidics and digital PCR. , 2012, Systematic and applied microbiology.

[15]  J. Mcarthur,et al.  Epitope Mapping of Human Anti-Adeno-Associated Virus Type 2 Neutralizing Antibodies: Implications for Gene Therapy and Virus Structure , 2000, Journal of Virology.

[16]  W. Ni,et al.  Development and Utility of an Internal Threshold Control (ITC) Real-Time PCR Assay for Exogenous DNA Detection , 2012, PloS one.

[17]  T. Conlon,et al.  Preclinical characterization of a recombinant adeno-associated virus type 1-pseudotyped vector demonstrates dose-dependent injection site inflammation and dissemination of vector genomes to distant sites. , 2007, Human gene therapy.

[18]  A. Mirmohammadsadegh,et al.  Safety and pharmacokinetics of naked plasmid DNA in the skin: studies on dissemination and ectopic expression. , 2001, The Journal of investigative dermatology.

[19]  W. Young,et al.  Establishing a novel single-copy primer-internal intron-spanning PCR (spiPCR) procedure for the direct detection of gene doping. , 2008, Exercise immunology review.

[20]  D. Scherman,et al.  Polymers for Improving the In Vivo Transduction Efficiency of AAV2 Vectors , 2010, PloS one.

[21]  H. Morizono,et al.  Systematic evaluation of AAV vectors for liver directed gene transfer in murine models. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  V. Beneš,et al.  Guidelines for Minimum Information for Publication of Quantitative Digital PCR Experiments , 2013 .

[23]  Alan McClelland,et al.  AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. , 2003, Blood.

[24]  P. Fagone,et al.  Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant. , 2013, Blood.

[25]  J. Descotes,et al.  Preclinical safety evaluation of human gene therapy products. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.

[26]  Alan McClelland,et al.  Quantification of adeno-associated virus particles and empty capsids by optical density measurement. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  T. Grist,et al.  Magnetic resonance imaging-monitored plasmid DNA delivery in primate limb muscle. , 2007, Human gene therapy.

[28]  P. Bourdon,et al.  The impact of long‐haul air travel on variables of the athlete's biological passport , 2012, International journal of laboratory hematology.

[29]  Manfred Schmidt,et al.  Integration Frequency and Intermolecular Recombination of rAAV Vectors in Non-human Primate Skeletal Muscle and Liver. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  M. Mascini,et al.  Simultaneous detection of transgenic DNA by surface plasmon resonance imaging with potential application to gene doping detection. , 2011, Analytical chemistry.

[31]  J. Hagstrom,et al.  Dose response in rodents and nonhuman primates after hydrodynamic limb vein delivery of naked plasmid DNA. , 2011, Human gene therapy.

[32]  Martial Saugy,et al.  Prevalence of blood doping in samples collected from elite track and field athletes. , 2011, Clinical chemistry.

[33]  J. Gerss,et al.  Long-term safety of intramuscular gene transfer of non-viral FGF1 for peripheral artery disease , 2011, Gene Therapy.

[34]  H. Stedman,et al.  Uniform Scale-Independent Gene Transfer to Striated Muscle After Transvenular Extravasation of Vector , 2005, Circulation.

[35]  R. Samulski,et al.  Adeno-associated virus serotypes: vector toolkit for human gene therapy. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  J. Mallet,et al.  Non-integrating lentiviral vectors. , 2008, Current gene therapy.

[37]  Anitha Rao,et al.  RNA-Based Gene Therapy for HIV with Lentiviral Vector–Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma , 2010, Science Translational Medicine.

[38]  D. Wells,et al.  Gene doping: the hype and the reality , 2008, British journal of pharmacology.

[39]  T. Friedmann.  How Close Are We to Gene Doping? , 2010, The Hastings Center report.

[40]  S. Kandarian,et al.  Normalization of muscle plasmid uptake by Southern blot: application to SERCA1 promoter analysis. , 1999, American journal of physiology. Cell physiology.

[41]  Alan McClelland,et al.  Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector , 2000, Nature Genetics.

[42]  J. Rasko,et al.  Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response , 2006, Nature Medicine.

[43]  Alexandra S. Whale,et al.  Comparison of microfluidic digital PCR and conventional quantitative PCR for measuring copy number variation , 2012, Nucleic acids research.

[44]  W. Al-Soud,et al.  Purification and Characterization of PCR-Inhibitory Components in Blood Cells , 2001, Journal of Clinical Microbiology.

[45]  K. Propert,et al.  Immune responses to adenovirus and adeno-associated virus in humans , 1999, Gene Therapy.

[46]  Edward S Boyden,et al.  Virally delivered channelrhodopsin-2 safely and effectively restores visual function in multiple mouse models of blindness. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[47]  A. Bagg,et al.  Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. , 2011, The New England journal of medicine.

[48]  G. S. Bains,et al.  Gene doping detection: evaluation of approach for direct detection of gene transfer using erythropoietin as a model system , 2010, Gene Therapy.

[49]  P. Gonin,et al.  Gene transfer vector biodistribution: pivotal safety studies in clinical gene therapy development , 2004, Gene therapy.

[50]  Sihong Song,et al.  Phase I trial of intramuscular injection of a recombinant adeno-associated virus serotype 2 alphal-antitrypsin (AAT) vector in AAT-deficient adults. , 2006, Human gene therapy.

[51]  Karine Tremblay,et al.  Efficacy and long term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open label trial , 2012, Gene Therapy.

[52]  Philip R. Johnson,et al.  Genetic Fate of Recombinant Adeno-Associated Virus Vector Genomes in Muscle , 2003, Journal of Virology.

[53]  C. von Kalle,et al.  Adeno-Associated Virus Vector Genomes Persist as Episomal Chromatin in Primate Muscle , 2008, Journal of Virology.

[54]  G. Repetto,et al.  Direct gene transfer into nonhuman primate myofibers in vivo. , 1992, Human gene therapy.

[55]  A. Cressant,et al.  Human alpha-iduronidase gene transfer mediated by adeno-associated virus types 1, 2, and 5 in the brain of nonhuman primates: vector diffusion and biodistribution. , 2009, Human gene therapy.

[56]  T. Friedmann,et al.  Gene Doping and Sport , 2010, Science.

[57]  I. Alexander,et al.  Potential use of gene transfer in athletic performance enhancement. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[58]  M. Penaud-Budloo,et al.  Longevity of rAAV vector and plasmid DNA in blood after intramuscular injection in nonhuman primates: implications for gene doping , 2011, Gene Therapy.